As your browser does not support javascript you won't be able to use all the features of the website. We strongly recommend you to enable the javascript in your old browser's settings or download a new one.

Pacira Pharmaceuticals (PCRX) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals ( PCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Pacira Pharmaceuticals as such a stock due to the following factors:

PCRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $32.9 million.

PCRX has traded 197,887 shares today.

PCRX is up 3.1% today.

PCRX was down 6% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PCRX with the Ticky from Trade-Ideas. See the FREE profile for PCRX NOW at Trade-Ideas More details on PCRX: Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. PCRX has a PE ratio of 51. Currently there are 6 analysts that rate Pacira Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Pacira Pharmaceuticals has been 833,100 shares per day over the past 30 days. Pacira has a market cap of $1.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.33 and a...